Form 4: Calix CEO Exercises Options, Sells Shares in Pre-Planned Trade

Calix President & CEO Michael Weening exercised stock options and subsequently sold 24,000 shares of common stock for $60 per share under a Rule 10b5-1 plan.

Summary

• Michael Weening, President & CEO and Director of Calix, Inc. (CALX), engaged in a pre-planned transaction on September 4, 2025.
• Weening exercised stock options to acquire 24,000 shares of common stock at an exercise price of $7.84 per share.
• Immediately following the option exercise, Weening sold 24,000 shares of common stock at a price of $60 per share.
• The sales were executed pursuant to a Rule 10b5-1 trading plan, which was adopted on February 28, 2025.
• After these transactions, Weening's direct beneficial ownership of Calix common stock stands at 16,117 shares.
• Weening retains 450,000 stock options (right to buy) following the reported transaction.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned insider sale following an option exercise, which is a routine event for executives. While it represents a reduction in direct ownership, the pre-planned nature mitigates negative signaling.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information.
• The significant difference between the option exercise price ($7.84) and the sale price ($60) indicates a substantial gain for the executive, reflecting past stock performance.

Negatives

• The transaction resulted in a reduction of Michael Weening's direct beneficial ownership of Calix common stock from 40,117 shares (after exercise) to 16,117 shares (after sale).

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports a routine insider transaction related to executive compensation and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: May observe a reduction in direct insider ownership, though the pre-planned nature of the sale under Rule 10b5-1 typically lessens concerns about management's view on future performance.

Key Dates

Recommendation

The Form 4 details a pre-planned exercise of stock options and subsequent sale of shares by the CEO. This is a common executive compensation event and, given the Rule 10b5-1 plan, does not necessarily signal a change in management's outlook on the company's future. Therefore, it does not warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Calix, CALX, Michael Weening, Insider Trading, Stock Option Exercise, Share Sale, Form 4, 10b5-1 Plan, CEO Transaction